Palivizumab in the prophylaxis of respiratory syncytial virus infection.

Palivizumab in the prophylaxis of respiratory syncytial virus infection.

Item
http://www.wikidata.org/entity/Q36278040
Respiratory viruses other than influenza virus: impact and therapeutic advancesA novel 5-lipoxygenase-activating protein inhibitor, AM679, reduces inflammation in the respiratory syncytial virus-infected mouse eyeAssembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins.Murine immune responses to virus-like particle-associated pre- and postfusion forms of the respiratory syncytial virus F proteinViral and host factors in human respiratory syncytial virus pathogenesis.Monoclonal antibodies for prophylaxis and therapy of infectious diseases.TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity.Respiratory syncytial virus prevention and therapy: past, present, and future.Whole genome characterization of non-tissue culture adapted HRSV strains in severely infected childrenAnimal models of respiratory syncytial virus infection.The fusion protein of respiratory syncytial virus triggers p53-dependent apoptosis.Relationship between the loss of neutralizing antibody binding and fusion activity of the F protein of human respiratory syncytial virusPathogenesis, humoral immune responses and transmission between co-housed animals in a ferret model of human RSV infection.Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn).
P2860

Palivizumab in the prophylaxis of respiratory syncytial virus infection.

Item
http://www.wikidata.org/entity/Q36278040
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Palivizumab in the prophylaxis of respiratory syncytial virus infection.
@ast
Palivizumab in the prophylaxis of respiratory syncytial virus infection.
@en
type
label
Palivizumab in the prophylaxis of respiratory syncytial virus infection.
@ast
Palivizumab in the prophylaxis of respiratory syncytial virus infection.
@en
prefLabel
Palivizumab in the prophylaxis of respiratory syncytial virus infection.
@ast
Palivizumab in the prophylaxis of respiratory syncytial virus infection.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Palivizumab in the prophylaxis of respiratory syncytial virus infection.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698